Group Therapy + MIDOMAFETAMINE for stress disorders, post-traumatic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Jul 2023: Trial registered, NCT05961527
  2. 1 Oct 2023: Trial started, NCT05961527

The trials

NCT05961527: Group MDMA-therapy for Veterans With PTSD

State
Completed
Phase
Phase 1 and Phase 2
People
23 taking part
Started
1 Oct 2023
Primary completion
14 Mar 2025
Arms
MDMA-assisted group therapy
Results
None posted
  1. 27 Jul 2023: Trial registered
  2. 1 Oct 2023: Trial started
  3. 14 Mar 2025: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.